x
Provider

Masoumeh Sadeghi, Professor of Cardiology

Masoumeh Sadeghi , MD

Full Professor


  Google Scholar

  Orcid

  Isid

  Pubmed

  Scopus

  • Phone: +98 311 36511208-10 
  • Email: sadeghimasoumeh@gmail.com, m_sadeghi@crc.mui.ac.ir
  • Date of birth :
  • CV: CV.DR SADEGHI. 1401_0.pdf (789.9 KB)

School :

School of Medicine

Department :

Department of Cardiology

Research Center :

Cardiac Rehabilitation Research Center, Cardiovascular Research Institute

work address :

Isfahan Cardiovascular Research Institute, Shahid Rahmani Alley, Moshtagh Sevom St., Isfahan, Iran.
Postal Code: 8158388994

Education :

Professor of cardiology.  Specialty in cardiology - Isfahan University of Medical Sciences. M.D Degree-Isfahan University of Medical Sciences.  

Relevant Work Experience :

  • Director of Cardiac Rehabilitation Research Center, Cardiovascular Research Institute WHO Collaborating Center, Isfahan University of Medical Sciences
  • Deputy of research, Shahid Chamran Heart Center and Heart Education Group, Isfahan University of Medical Sciences.
  • Editor in Chief, ARYA Atherosclerosis Journal.
  • Faculty Member, Isfahan University of Medical Sciences.

 

Professional Memberships & Qualification :

  • Heart group of Isfahan school of medicine, Isfahan University of Medical Sciences.
  • Research Committee of Isfahan School of medicine, Iran.
  • Research Committee of Isfahan Cardiovascular Research Center, Iran.
  • Scientific Committee, National Project for Cardiovascular Prevention and Control.
  • Iranian Heart Foundation, Iran.
  • Iranian Chapter of Heart Friends around the World.
  • Coordinator Committee, Isfahan Healthy Heart Program.
  • Member of research council, Isfahan Cardiovascular Research Center.
  • Member of research branch of heart group Isfahan medical school
  • Reviewer member of Nutrition & Dietetics journal.
  • Member of National Ethics Committee, Ministry of Health and Medical Education.
  • Reviewer member of JACC Asia journal.
  • Reviewer member of The Global Burden of Disease Study (GBD)
  • Collaboration with the World Heart Organization (WHO) as a member of the Development group for ischemic heart disease to the development of World Health Organizations (WHO) Package of Interventions for Rehabilitation (PIR).
  • Collaboration with the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR) as a Member of ICCPR CR Data Dictionary Panel (Cardiac Rehab Data Dictionary - Delphi Panelist (
  • Collaboration with the European Society of Cardiology (ESC)
  • Collaboration with the Canadian Association of Cardiovascular Prevention and Rehabilitation (CACPR)
  • Collaboration with the Heart Friends around the World Association.
  • Collaboration with the World Heart FEDERATION (WHF).
  • Certification of WHO to participate in Clinical management of patients with COVID-19 - Rehabilitation of patients with COVID-19.

Extra Curricular Activities/ Interest(personal url) :

Grants & Awards :

  1. Effect of cardiac rehabilitation on metabolic syndrome and its components: A systematic review and Meta analysis.2013.
  2. Effect of cardiac rehabilitation on inflammatory markers: A systematic review and Meta analysis.2013.
  3. A Study on the effectiveness of a comprehensive home based cardiac rehabilitation intervention on the health promotion of patient with coronary artery disease.2015.
  4. The Association between APOAC4 gene polymorphisms and premature myocardial infarction in Iranian population.2016.
  5. Adherence to and cost-effectiveness of a polypill versus usual care for secondary prevention of cardiovascular diseases in patients with a history of acute coronary syndrome in Isfahan, Iran, a randomized clinical trial.2017.
  6. Developing risk assessment charts for predicting cardiovascular events in breast and colorectal cancer patients. A 3 year (first phase) multicenter cohort study (fast track).2017.
  7. Evaluation the effect of the fenugreek hydrolyzed protein on lipids and CRP levels in hypercholesterolemia patients.2019.
  8. Mortality rates and 15 years’ predictors of death in Isfahan cohort study on individuals above 35 years old.2019.
  9. Cardiovascular risk assessment of the population and comparison of WHO/ISH risk assessment scores with Framingham risk assessment function and its clinical and public health implications. (CAP Study). 
  10. Gluteal – Abdominal Adipose Tissue Measurement in Ischemic patients. (GAAMI Study). 
  11. Cardiac Rehabilitation Program Survey - Global Study. Cooperation with ICCPR. 
  12. Acute Coronary Syndrome (ACS) STEMI Registry. Cooperation with European Heart Association. 
  13. Developing suitable model for self-care of cardiac Patients. Cooperation with World Health Organization. 
  14. Programme Non-ST-segment elevation myocardial infarction. Cooperation with European Heart Association. 

Patents :

Presentations & Poster Sessions :

  1. Sadeghi M. Effect of cardiac rehabilitation on severe left ventricular dysfunction. 2000 Philippines: February 20-24.
  2. Sadeghi M. The effect of exercise rehabilitation program on the psychological condition and functional capacity of patient with congestive heart failure. 2001 Malaysia: January 11-13.
  3. Sadeghi M. The effect of phase II rehabilitation on systolic and diastolic Blood pressure. 2001 Italy: October 12-14.
  4. Sadeghi M. Effect of smoking on left venticular mass, apolipoprotein and Insulin level. Sex based difference of rehabilitation program among cardiac patient. 2001 Hong Kong: November 2-24.
  5. Sadeghi M. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Presenting a lecture about 'women Healthy heart-an Iranian experience'. 2002 Egypt: April 10-13.
  6. Sadeghi M. 'the anti oxidant activity of the essential oils of Iranian conifers on red blood cell'. "Carotid Intima-Media thickness as an independent predictor of atherosclerosis'. 2002 Australia: October 4-6.
  7. Sadeghi M. 'The prevalence of dyslipidemia in Iranian population'.   2003 Swiss: February 11-15.
  8. Sadeghi M. High blood pressure and associated cardiovascular risk factors. 2003, Kyoto-Japan September 28-October2.
  9. Sadeghi M. Heart rate variability in obese children. 2003, Thailand.
  10. Sadeghi M. The effect of rehabilitation program on the psychological condition and functional capacity of patients with congestive heart failure. 2005, January 9-12 Singapore.
  11.  Sadeghi M. Obesity and association with other cardiovascular risk factors.2005, 29 Oct-1 Nov Turkey.
  12.  Sadeghi M. The effect of smoking habit on C-reactive protein in Iranian population.2005, 5-9December- India.
  13. Sadeghi M. Lipid level in uncomplicated no diabetic hypertensive. 2006, 18-22 June, Rome-Italy.
  14. Sadeghi M. Comprehensive Community Interventions to Prevent Cardiovascular Disease in a Developing Country. 2010, 16-19 June, Beijin-china.
  15. Sadeghi M.  4th International Congress on Prediabetes and the Metabolic Syndrome, Madrid, Spain, April 6-9, 2011.
  16. Sadeghi M.  Association of apolipoprotein B, apolipoprotein A, and the apolipoprotein B/apolipoprotein a ratio with body fat indicators the World Congress of Cardiology 2012 taking place from 18-21 April 2012 in Dubai, United Arab Emirates.
  17. Sadeghi M.  Is there any relation between Circulating Endothelial-Leukocyte adhesion molecule -1 and extent of coronary artery involvements in men with angina pectoris? 8th Congress of Update in Cardiology and Cardiovascular Surgery (UCCS) Antalya, Turkey, 1 - 4 March 2012.
  18. Sadeghi M, Roohafza H, Gharipour M, Sarrafzadegan N. ARYA Atherosclerosis Journal. MedicReS World Congress June 06 - 09 2012 Vienna –Austria.
  19.  Sadeghi M, Association between air pollutants and heart failure symptom exacerbation leading to hospitalization. ESC Congress 2013, 31 Agust-4 Sep Amsterdam- Netherlands.
  20. Sadeghi M, the Impacts of Cardiac Rehabilitation Program on Echocardiographic Parameters in Coronary Artery Disease Patients with Left Ventricular Dysfunction. The First NCD Congress, 09-11 January 2014 Dubai.
  21. Sadeghi M, The Impacts of Cardiac Rehabilitation Program on Functional Status and Quality of Life of Coronary Artery Disease Patients with Left Ventricular Dysfunction. The World Heart Federation's World Congress of Cardiology 4-7 May 2014 Melbourne, Australia.
  22. Sadeghi M, weight changes in men with coronary artery disease after cardiac rehabilitation program. 1th International Congress of Cardiac Rehabilitation from Research to Practice, 21-23 Oct 2014, Isfahan.
  23. Sadeghi M. Presenting a lecture in 4th International Preventive Cardiology Congress. From 30 september-2october 2015 in Cardiovascular Research Center, Shiraz, Iran.
  24. Sadeghi M. 4th annual Medical Ethics Congress. 6 -9 bahman 2015 in Tehran, Iran.
  25. Sadeghi M. Is selenium supplementation knockdown the expression of seps1 in patients with metabolic syndrome and history of cardiovascular disease?  International Symposium on Atherosclerosis (ISA) Location: Toronto, CANADA Date: JUN 09-12, 2018.
  26. Sadeghi M. Effects of selenium supplementation on expression of sepp1 in subjects with t metabolic syndrome and history of cvd: a double-blind randomized controlled trial. International Symposium on Atherosclerosis (ISA) Location: Toronto, CANADA Date: JUN 09-12, 2018.
  27. Sadeghi M. Association between plasma lipid disorders and 12-years cardiovascular events - isfahan cohort study (ics). International Symposium on Atherosclerosis (ISA) Location: Toronto, CANADA Date: JUN 09-12, 2018.
  28. Sadeghi M. Changes of inflammatory markers' level during hospitalization in patients with acute myocardial infarction with and without depression. International Symposium on Atherosclerosis (ISA) Location: Toronto, CANADA Date: JUN 09-12, 2018.
  29. Gharipour, M.; Sadeghi, M.; Talaie, M.; Sarrafzadegan, N. anthropometric indices predicting incident hypertension in an iranian population: the isfahan cohort study. Journal of Hypertension: June 2015; 33: p e394. doi: 10.1097/01.hjh.0000468607.43788.
  30. Sadeghi, M, et al. Fixed combination therapy for secondary prevention of major cardiovascular events: design and protocol for Persian Polypill Study, a randomized clinical trial. 19th International Symposium on Atherosclerosis (ISA2021)

Research Experience :

  • Having passed the research method workshop held by ministry of heath
  • Having passed medical writing workshop.
  • Having passed clinical trial workshop (Hong Kong).
  • Having passed clinical trial workshop (Iran).
  • Having passed clinical trial workshop on secondary prevention of myocardial infarction and stroke and management of cardiovascular risk (held by WHO).
  • Having passed the global forum NCD prevention and control: rotating international visitors program 2003 (organized by WHO/HQ and EMRO).
  • Having passed 3- weeks training program in cardiovascular disease rehabilitation and prevention (Melbourne-Australia).
  • Having passed 2- weeks training program in cardiovascular disease psychosomatic (Freiburg-Germany).
  • Having passed 150-hour training program in clinical anformatic fellowship (Kerman-Iran).
  • Having passed international training program in ICCPR cardiovascular rehabilitation foundations certification.

Research Interests :

Cardiovascular risk assessment of the population and comparison of WHO/ISH risk assessment scores with Framingham risk assessment function and its clinical and public health implications. Cooperation with World Health Organization "GAAMI Study" Gluteal – Abdominal Adipose tissue Measurement in Ischemic patients. Cooperation with MC Gill University, Mike Rosen bloom Lab for cardiovascular Research, Montreal, Quebec Cardiac Rehabilitation Program Survey - Global Study. Cooperation with ICCPR Acute Coronary Syndrome (ACS) STEMI Registry. Cooperation with European Heart Association. Developing suitable model for self-care of cardiac Patients. Grant by  World Health Organization Programme Non-ST-segment elevation myocardial infarction- Cooperation with ESC

Teaching Experience :

Teaching Interests :